Logo

Flanders Institutes Purchase Roche/454 Sequencer

Nov 06, 2007
NEW YORK (GenomeWeb News) - The Flanders Institute for Biotechnology and the Catholic University of Leuven said today that they have jointly purchased a sequencer from Roche subsidiary 454 Life Sciences.
 
The sequencer will be housed in the Genetic Service Facility of the Flanders Institute for Biotechnology’s Department of Molecular Genetics at the University of Antwerp, but the organizations said the system will available to other Flemish researchers.
 
The new sequencing capacity will be used to sequence “new, full genomes of interesting organisms” and to trace genetic variations that cause illnesses.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.